Around 2,600 people are diagnosed with cervical cancer each year in England
The deal to develop a small-molecule inhibitor could be worth over $480m
The biologics manufacturing site is expected to create more than 300 highly skilled jobs
Sonoma will receive $75m upfront and will be eligible for a $45m milestone payment
The platform makes it easy to find and apply for jobs in the pharmaceutical and life sciences industry
It is estimated there will be around 66,000 new cases of uterine cancer in the US this year
The company has already started clinical trials assessing four new infectious disease vaccines
Over two and a half million adults with mild cases of asthma could be eligible for the treatment
The draft guidance discusses the advantage of randomised clinical trials over single-arm studies
PME interviews VMLY&Rx's CEO
PME interviews Virgo Health's head of health
PME interviews Ashfield Health's Global President
Patients with inherited white matter disorders will benefit from earlier diagnosis and specialist care
The tests can identify the presence of bacteria in a urine sample in less than 40 minutes
More than 52,000 men are diagnosed with prostate cancer every year in the UK alone
These diseases were responsible for an estimated 40 million of all deaths globally in 2019
Insulin resistance affects around 15.5% to 46.5% of the world’s population
The regulator has requested more information on the pump used to administer ABBV-95
The changes will aim to make it easier to gain approval and to run clinical trials in the UK
Christmas joins from Vynamic, where she founded the firm’s DE&I efforts in 2016
Zahraie was previously global innovation lead and associate managing director at Havas Health & You
Arnhofer was most recently senior vice president of customer strategy at BioNTech SE
Tucker was previously chief executive officer of Obsidian Healthcare Group
Nash was most recently Ogilvy’s chief operating officer in North America